首页 | 本学科首页   官方微博 | 高级检索  
检索        

我院2008-2010年抗肿瘤药应用分析
引用本文:许隽,卢弢.我院2008-2010年抗肿瘤药应用分析[J].辽宁药物与临床,2012(1):36-38.
作者姓名:许隽  卢弢
作者单位:[1]南京市胸科医院药剂科,210029 [2]南京第二医院药剂科,南京210029
摘    要:目的评价我院2008-2010年抗肿瘤药的应用情况和发展趋势。方法采用金额排序法、用药频度(DDDs)分析法,对我院2008-2010年抗肿瘤药的应用情况进行统计与分析。结果3年中,抗肿瘤药销售金额、DDDs均逐年增加,香菇多糖DDDs排名稳居榜首,多西他赛销售金额位于前2位。结论我院抗肿瘤药品种基本保持稳定,并具有价格更合理、疗效更确切、不良反应更小的趋势。

关 键 词:抗肿瘤药  销售金额  用药频度

Analysis of antineoplastics use in our hospital from 2008 to 2010
XU Jun,LU.Analysis of antineoplastics use in our hospital from 2008 to 2010[J].Liaoning Pharmacy and Clinical Remedies,2012(1):36-38.
Authors:XU Jun  LU
Institution:Tao(1.Department of Pharmacy,Nanjing Chest Hospital,Nanjing 210029,China;2.Department of Pharmacy,The Second Hospital of Nanjing,Nanjing 210029,China)
Abstract:Objective To evaluate the application and trends of antineoplastics in our hospital from 2008 to 2010.Methods The antineoplastics use in our hospital from 2008 to 2010 were statistically analyzed by the analysis of consumption sum and DDDs.Results In the 3 years,both consumption sum and DDDs of antineoplastics increased year by year.The DDDs of lentinan ranked for the first place,and docetaxel for injection was in the top 2 of sales amount.Conclusion The antineoplastics use in our hospital basically remain stable in category in recent years,that focus on the reasonable price,exact therapeutic effect and less adverse reaction.
Keywords:Antineoplastic drugs  Consumption sum  DDDs
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号